Default company panoramic image
B502a292 da16 4a55 a186 9c2379bcf687


Adipologix is developing a revolutionary soft tissue regeneration technology for the multi-billion dollar cosmetic & reconstructive plastic surgery markets.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Kingston, ON, Canada
  • Currency USD
  • Founded December 2013
  • Employees 2

Company Summary

Adipologix is developing regenerative medicine solutions for reconstructive & cosmetic plastic surgery procedures. The company’s patented decellularized adipose tissue technology is an innovative biomaterial that promotes the natural regeneration of the patient’s own tissues and provides plastic surgeons with an easy and cost-effective option for repairing or augmenting soft tissues of the face, breast, and body naturally and permanently.


  • 0a3c3d01 a293 4ff4 9d7f 64865cba8b3a

    Mr. Hendry has over a decade of experience in technology development & commercialization including the successful commercialization of a bone biomaterial technology platform. Mr. Hendry has a Masters degree in biomaterials from the University of Toronto and has managed all aspects of the product development cycle including product & process development, manufacturing scale-up, regulatory affairs, clinical evaluation, and product launch.

  • 48ce8900 ab89 4350 bbe4 0451c9908e6d
    Vice President

    Dr. Lauren Flynn is an Associate Professor at the University of Western Ontario and inventor of Adipologix's soft tissue regeneration technology. She has a Ph.D. in chemical engineering from the Institute of Biomaterials & Biomedical Engineering (University of Toronto) and her current research is focused on the development of new cell-based regenerative approaches with adipose-derived stem cells (ASCs) and naturally-derived bioscaffolds.